A meta-analysis of randomized head-to-head trials of atorvastatin versus rosuvastatin for reductions in C-reactive protein

International Journal of Cardiology

Volumn 154, Issue 1, 2012, Pages 78-81

  Takagi, Hisato ^a   Umemoto, Takuya ^a  

^a SHIZUOKA MEDICAL CENTER   (Japan)

Author keywords

Atorvastatin; C reactive protein; Meta analysis; Randomized head to head trial; Rosuvastatin

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; ROSUVASTATIN;

ANTIINFLAMMATORY ACTIVITY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DRUG EFFICACY; DRUG TARGETING; DYSLIPIDEMIA; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; LETTER; META ANALYSIS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; TREATMENT DURATION;

EID: 82655187424     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.09.065     Document Type: Article

References (20)

1. Emerging Risk Factors Collaboration S. Kaptoge, and E. Di Angelantonio C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis Lancet 375 2010 132 140
2. B. Genser, T.B. Grammer, T. Stojakovic, R. Siekmeier, and W. März Effect of HMG CoA reductase inhibitors on low-density lipoprotein cholesterol and C-reactive protein: systematic review and meta-analysis Int J Clin Pharmacol Ther 46 2008 497 510
3. J.P. Higgins, J.J. Deeks Chapter 7: selecting studies and collecting data J.P. Higgins, and S. Green Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011) 2011 The Cochrane Collaboration Available from www.cochrane-handbook.org
4. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
5. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634 (Pubitemid 27387172)
6. P. Anagnostis, D. Selalmatzidou, and S.A. Polyzos Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study Int J Clin Pract 65 2011 679 683
7. K.C. Ferdinand, L.T. Clark, and K.E. Watson Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trial Am J Cardiol 97 2006 229 235 (Pubitemid 43139241)
8. H.J. Milionis, E. Rizos, and M. Kostapanos Treating to target patients with primary hyperlipidaemia: comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study) Curr Med Res Opin 22 2006 1123 1131 (Pubitemid 44000732)
9. N.D. Brunetti, G. Maulucci, and G.P. Casavecchia Improvement in endothelium dysfunction in diabetics treated with statins: a randomized comparison of atorvastatin 20 mg versus rosuvastatin 10 mg J Interv Cardiol 20 2007 481 487 (Pubitemid 350179463)
10. A.F. Stalenhoef, C.M. Ballantyne, and C. Sarti A comparative study with rosuvastatin in subjects with metabolic syndrome: results of the COMETS study Eur Heart J 26 2005 2664 2672 (Pubitemid 41746689)
11. E.A. Stein, K. Strutt, H. Southworth, P.J. Diggle, E. Miller HeFH Study Group Comparison of rosuvastatin versus atorvastatin in patients with heterozygous familial hypercholesterolemia Am J Cardiol 92 2003 1287 1293 (Pubitemid 37431136)
12. Y.J. Hong, M.H. Jeong, and D. Hachinohe Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis Circ J 75 2011 398 406
13. J.S. Park, Y.J. Kim, and J.Y. Choi Comparative study of low doses of rosuvastatin and atorvastatin on lipid and glycemic control in patients with metabolic syndrome and hypercholesterolemia Korean J Intern Med 25 2010 27 35
14. K. Saku, B. Zhang, K. Noda PATROL Trial Investigators Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): the PATROL trial Circ J 75 2011 1493 1505
15. L. Puccetti, F. Santilli, and A.L. Pasqui Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia Atherosclerosis 214 2011 122 128
16. H.Y. Qu, Y.W. Xiao, G.H. Jiang, Z.Y. Wang, Y. Zhang, and M. Zhang Effect of atorvastatin versus rosuvastatin on levels of serum lipids, inflammatory markers and adiponectin in patients with hypercholesterolemia Pharm Res 26 2009 958 964
17. I.K. Karalis, S.C. Bergheanu, and R. Wolterbeek Effect of increasing doses of Rosuvastatin and Atorvastatin on apolipoproteins, enzymes and lipid transfer proteins involved in lipoprotein metabolism and inflammatory parameters Curr Med Res Opin 26 2010 2301 2313
18. N. Thongtang, M. Ai, and S. Otokozawa Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation Am J Cardiol 107 2011 387 392
19. T. Tsutamoto, H. Sakai, and K. Ibe Effect of atorvastatin vs. rosuvastatin on cardiac sympathetic nerve activity in non-diabetic patients with dilated cardiomyopathy Circ J 75 2011 2160
20. M. Endres Statins: potential new indications in inflammatory conditions Atheroscler Suppl 7 2006 31 35